California State Teachers Retirement System (CalSTRS)’s Rapport Therapeutics RAPP Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio RAPP Stock Details RAPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Buy	33,426 +6,736	+25%	+$189K	﹤0.01%	1800
2025 Q4	$810K	Buy	26,690 +25,594	+2,335%	+$708K	﹤0.01%	1887
2025 Q3	$32.6K	Buy	1,096 +1	+0.1%	+$18	﹤0.01%	2385
2025 Q2	$12.4K	Sell	1,095 -28,844	-96%	-$306K	﹤0.01%	2658
2025 Q1	$300K	Buy	29,939 +21,368	+249%	+$277K	﹤0.01%	2236
2024 Q4	$152K	Buy	8,571 +7,886	+1,151%	+$175K	﹤0.01%	2363
2024 Q3	$14K	Buy	+685	New	+$14.7K	﹤0.01%	2762

Other funds holding RAPP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGV

TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s RAPP Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Rapport Therapeutics (RAPP) stake by 25% in Q1 2026, buying an estimated $189K and bringing the position to 33,426 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

California State Teachers Retirement System (CalSTRS) first reported a position in RAPP in Q3 2024 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

California State Teachers Retirement System (CalSTRS) held 33,426 shares of Rapport Therapeutics worth $1.05M as of Q1 2026.
California State Teachers Retirement System (CalSTRS) bought 6,736 Rapport Therapeutics shares in Q1 2026, an estimated $189K.
Rapport Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1800 holding.
California State Teachers Retirement System (CalSTRS) first reported a position in Rapport Therapeutics in Q3 2024 and has held it in 7 quarters since.
147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.